Brevan Howard Capital Management’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-33,511	Closed	-$155K	–	1112
2024 Q2	$155K	Buy	33,511 +17,985	+116%	+$83.1K	﹤0.01%	879
2024 Q1	$127K	Buy	+15,526	New	+$127K	﹤0.01%	817